To investigate the effect of EZH2 on HCC cell growth and senescence, we used EZH2 inhibitors to interfere with its enzyme activity and siRNAs and shRNAs to decrease its expression in the BEL7404 and SMMC7721 cell lines. This evidence concerns the gene EZH2 and hepatocellular carcinoma.